Multi-analyte Affinity Column for Toxin Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current multi-analyte affinity columns face challenges in effectively detecting a plurality of toxins, such as aflatoxin, deoxynivalenol, fumonisin, ochratoxin, T-2, and zearalenone, in a single sample due to the complexity of preparing columns that can treat all target analytes similarly, leading to unsatisfactory analytical results when simply combining resin quantities from single-analyte columns.
Innovation Solution
A multi-analyte column is developed comprising specific antibodies for each toxin, with optimized resin quantities and configurations to ensure efficient binding and analysis, allowing for the detection of multiple toxins in a single sample, including aflatoxins G1, G2, B1, B2, M1, deoxynivalenol, fumonisins B1, B2, B3, ochratoxin A, T-2, and zearalenone, with a focus on achieving high recovery rates and flow rates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If resin quantities from single-analyte columns are simply combined, then the column can detect multiple toxins, but the analytical results are unsatisfactory
Solution Approach 1:
The affinity column is divided into multiple distinct resin sections, each containing antibodies specific to different toxin types. This segmentation allows each resin to be optimized for its specific target analyte while working together in a single column system, resolving the contradiction between multi-analyte capability and analytical precision.
Solution Approach 2:
The affinity column is designed as a universal platform that can detect multiple different toxins (aflatoxins, ochratoxin, zearalenone, deoxynivalenol, fumonisin, T-2 toxin) simultaneously. By integrating multiple specific antibody-resin combinations into one column, it achieves multi-functionality while maintaining detection precision for each analyte type.
2Adaptability or versatility
If the column is designed to treat all target analytes similarly, then preparation complexity increases, but detection of multiple toxins is enabled
Solution Approach 1:
Rather than creating a single homogeneous resin that attempts to bind all toxins equally, the column is segmented into distinct resin sections, each optimized for specific toxin types. This segmentation reduces preparation complexity by allowing each resin to be independently optimized and assembled, rather than requiring a complex universal resin formulation.
Solution Approach 2:
Antibodies serve as intermediary molecules that enable specific toxin-resin interactions. Each resin is coated with antibodies specific to particular toxins, acting as mediators that simplify the interaction between the diverse toxin analytes and the resin matrix, thereby reducing overall system complexity.
3Reliability
If antibodies specific for each toxin are incorporated with optimized resin quantities, then recovery rates improve, but column configuration complexity increases
Solution Approach 1:
Each resin section in the column is given local quality optimization with specific antibody coatings and resin quantities tailored to the particular toxin type it targets. This local optimization ensures high recovery rates for each analyte while the overall column structure remains organized and manageable through systematic segmentation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The multi-analyte column achieves satisfactory analytical results with high recovery rates (at least 60%) and fast flow rates (at least 3 ml per minute), enabling the detection of multiple toxins in a single sample with improved efficiency and accuracy.
Implementation Method 1
an affinity matrix and a method for the detection of low molecular weight compositions such as aflatoxins are provided utilizing specific monoclonal IgM antibody
Data Source
AI summary
A multi-analyte column is disclosed. The column may contain at least one unit of resin having ochratoxin specific affinity and, for each unit of resin having ochratoxin specific affinity, the column further contains about 0.95 to 1.05 units of resin containing antibody having specificity for zearalenone, about 1.9 to 2.1 units of resin containing antibody having specificity for aflatoxin., about 2.35 to 2.65 units of resin containing antibody having specificity for fumonisin, about 2.8 to 3.2 units of resin containing antibody having specificity for T-2 (and/or HT-2) and about 4.7 to 5.3 units of resin containing antibody having specificity for deoxynivalenol. One unit of resin is the quantity of resin containing antibody that will bind 50 ng of aflatoxin, 500 ng of deoxynivalenol, 3300 ng of fumonisin, 50 ng of ochratoxin, 830 ng T- 2 (and/or HT-2) or 1140 ng of zearalenone, respectively.